½ÃÀ庸°í¼­
»óǰÄÚµå
1596768

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çü, ¼³Ä¡, ¾ç½Ä ¹× ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Stroke Post Processing Software Market by Type (Hemorrhagic Stroke, Ischemic Stroke), Installation (Desktop, Mobile Phones & Tablets), Modality, End-use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 2¾ï 769¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 2¾ï 2,900¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.74%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 4¾ï 2,436¸¸ ´Þ·¯¿¡ À̸¥´Ù°í ¿¹ÃøµË´Ï´Ù.

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ÀÇ·á ±â¼ú »ê¾÷¿¡¼­ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ´Â ºÐ¾ß·Î, ³úÁ¹Áß °ü·Ã ¿µ»ó Áø´Ü ¹× ºÐ¼® °­È­¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÁÖ·Î MRI ¹× CT ¿µ»ó¿¡ ÀÇÇÑ ³ú ½ºÄµÀ» ó¸®Çϰí ÇØ¼®ÇÏ¿© ³úÁ¹Áß Áø´Ü ¹× Ä¡·á ÀÇ»ç°áÁ¤ÀÇ ¼Óµµ¿Í Á¤È®¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¼³°èµÈ ÀÚµ¿È­ ¹× ¹ÝÀÚµ¿È­ µµ±¸°¡ ±× ¹üÀ§¿¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾îÀÇ Çʿ伺Àº ³úÁ¹Áß È¯ÀÚ Ä¡·á¿Í °ü·ÃµÈ Áß¿äÇÑ ½Ã°£Àû Á¦¾àÀ¸·Î ÀÎÇØ È¿À²ÀûÀÌ°í ½Å¼ÓÇÑ ºÐ¼®Àº Ä¡·á °á°ú¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í Ä¡·á ½Ã°£À» ´ÜÃàÇϰí ȸº¹·üÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÃÖ±ÙÀÇ ¹ßÀüÀ¸·Î ¿ø°Ý ÀÇ·á Ç÷§Æû, ÀÀ±Þ ÀÇ·á ȯ°æ, º´¿ø ³×Æ®¿öÅ©¿¡ ÅëÇյǴ µî ±× ¿ëµµ°¡ Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â ½Å°æ°ú ÀÇ»ç, ¹æ»ç¼±°ú ÀÇ»ç, ÀÀ±Þ ÀÇ·á ÆÀ, ´õ ³ªÀº ȯÀÚ °ü¸®¸¦ ÃËÁøÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â µµ±¸¸¦ ¿øÇÏ´Â ÀÇ·á ±â°ü µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ³úÁ¹Áß ¹ß»ý·ü Áõ°¡, Á¶±â Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÌ·¯ÇÑ µµ±¸ÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â ÀΰøÁö´É ¹× ¸Ó½Å·¯´×ÀÇ ±â¼ú ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ Àû¿ë È®´ë, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç °³¹ßÀ» ÅëÇÑ Á¢±Ù¼º Çâ»ó, º¸´Ù ±¤¹üÀ§ÇÑ ÀüÀÚ ÀÇ·á ±â·Ï ½Ã½ºÅÛ°úÀÇ ÅëÇÕ µî »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº ¼ÒÇÁÆ®¿þ¾î µµÀÔ ¹× À¯Áöº¸¼ö ºñ¿ë, ±ÔÁ¦ À庮, ºü¸¥ ±â¼ú ¹ßÀü¿¡ µû¸¥ Áö¼ÓÀûÀÎ ¾÷µ¥ÀÌÆ®ÀÇ Çʿ伺 µîÀÇ °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. À̸¦ ±Øº¹Çϱâ À§ÇØ ±â¾÷µéÀº ¼ÒÇÁÆ®¿þ¾îÀÇ »óÈ£¿î¿ë¼º Çâ»ó, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º °³¼±, ´Ù¾çÇÑ ÀÓ»ó ¿öÅ©Ç÷ο쿡 ÀûÀÀÇÒ ¼ö ÀÖ´Â ¸ðµâÇü ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç °³¹ß µî Çõ½Å ºÐ¾ß¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í Çù·ÂÇÏ¿© ½ÇÁ¦ ¿ëµµ¿¡ ´ëÇÑ Çǵå¹éÀ» Á¦°øÇÔÀ¸·Î½á ±â´É¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¾Ë°í¸®Áò Á¤È®µµ Çâ»ó, À§¾ç¼º·ü °¨¼Ò, ½Ç½Ã°£ ó¸® ´É·Â Çâ»ó¿¡ ´ëÇÑ ¿¬±¸¿¡ ÁýÁßÇÏ¸é ½ÃÀå ħÅõ»Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â Å« ±âȸ°¡ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 2¾ï 769¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 2¾ï 2,900¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 4¾ï 2,436¸¸ ´Þ·¯
CAGR(%) 10.74%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³úÁ¹Áß ¹× ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ÇコÄÉ¾î ºÐ¾ßÀÇ µðÁöÅÐÈ­
    • ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ ¹ßÀüÀ» À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÅõÀÚ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ¼Ö·ç¼Ç ºñ¿ë
  • ½ÃÀå ±âȸ
    • ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾îÀÇ Áøº¸
    • À¯ÀüüÇп¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø È®´ë
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ ºÎÁ·

Portre's Five Forces: ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ±â¾÷Àº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ÃâÇ÷¼º ³úÁ¹Áß
  • ÇãÇ÷¼º ³úÁ¹Áß

Á¦7Àå ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÀνºÅ纰

  • µ¥½ºÅ©Åé
  • ÈÞ´ëÆù ¹× ÅÂºí¸´

Á¦8Àå ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • CT ½ºÄµ
  • MRI

Á¦9Àå ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • Àü¹®¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Arterys Inc.
  • Brainomix Limited
  • Cercare Medical A/S
  • Circle Cardiovascular Imaging Inc.
  • General Electric Company
  • icometrix NV
  • Imaging Biometrics, LLC
  • Infervision Medical Technology Co., Ltd.
  • iSchemaView, Inc.
  • Olea Medical S.A.S.
  • Viz.ai, Inc.
  • Vizient, Inc.
LSH

The Stroke Post Processing Software Market was valued at USD 207.69 million in 2023, expected to reach USD 229.00 million in 2024, and is projected to grow at a CAGR of 10.74%, to USD 424.36 million by 2030.

The stroke post-processing software market is a rapidly evolving sector within the medical technology industry, focusing on enhancing diagnostic imaging and analysis related to strokes. Its scope encompasses automated and semi-automated tools designed to process and interpret brain scans, primarily from MRI and CT imaging, to improve the speed and accuracy of stroke diagnosis and treatment decision-making. The necessity of such software is driven by the critical time constraints involved in treating stroke patients, where efficient and quick analysis can significantly impact outcomes, reduce treatment times, and improve recovery rates. Recent advancements have expanded its applications, including the integration into telemedicine platforms, emergency care settings, and hospital networks globally. End-users include neurologists, radiologists, emergency medical teams, and healthcare institutions looking for reliable tools to facilitate better patient management. Key factors influencing growth in this market include rising incidences of strokes, growing awareness about the benefits of early diagnosis, and technological advancements in artificial intelligence and machine learning, which enhance the accuracy and efficiency of these tools. New opportunities lie in expanding application in emerging markets, developing cloud-based solutions to increase accessibility, and integrating with broader electronic health record systems. However, this market faces challenges such as the high cost of software deployment and maintenance, regulatory hurdles, and the need for continuous updates to align with the fast-paced technological advancements. To overcome these, companies should focus on innovation areas such as enhancing software interoperability, improving user interfaces, and developing modular software solutions that can adapt to various clinical workflows. Furthermore, collaboration with healthcare providers for real-world application feedback can help refine functionality and usability. By concentrating research on improving algorithm accuracy, reducing false-positive rates, and advancing real-time processing capabilities, there are significant opportunities to enhance not only market penetration but also patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 207.69 million
Estimated Year [2024] USD 229.00 million
Forecast Year [2030] USD 424.36 million
CAGR (%) 10.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stroke Post Processing Software Market

The Stroke Post Processing Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of stroke and heart disorders
    • Digitalization of healthcare sector
    • Governmental iniatives and investments for advancement of healthcare solutions
  • Market Restraints
    • High costs of solutions
  • Market Opportunities
    • Advancements in stroke post processing software
    • Increased government funding towards genomics
  • Market Challenges
    • Scarcity of skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Stroke Post Processing Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stroke Post Processing Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stroke Post Processing Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stroke Post Processing Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stroke Post Processing Software Market

A detailed market share analysis in the Stroke Post Processing Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stroke Post Processing Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stroke Post Processing Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stroke Post Processing Software Market

A strategic analysis of the Stroke Post Processing Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stroke Post Processing Software Market, highlighting leading vendors and their innovative profiles. These include Arterys Inc., Brainomix Limited, Cercare Medical A/S, Circle Cardiovascular Imaging Inc., General Electric Company, icometrix NV, Imaging Biometrics, LLC, Infervision Medical Technology Co., Ltd., iSchemaView, Inc., Olea Medical S.A.S., Viz.ai, Inc., and Vizient, Inc..

Market Segmentation & Coverage

This research report categorizes the Stroke Post Processing Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Hemorrhagic Stroke and Ischemic Stroke.
  • Based on Installation, market is studied across Desktop and Mobile Phones & Tablets.
  • Based on Modality, market is studied across CT Scan and MRI.
  • Based on End-use, market is studied across Hospitals & Clinics and Specialty Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of stroke and heart disorders
      • 5.1.1.2. Digitalization of healthcare sector
      • 5.1.1.3. Governmental iniatives and investments for advancement of healthcare solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in stroke post processing software
      • 5.1.3.2. Increased government funding towards genomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stroke Post Processing Software Market, by Type

  • 6.1. Introduction
  • 6.2. Hemorrhagic Stroke
  • 6.3. Ischemic Stroke

7. Stroke Post Processing Software Market, by Installation

  • 7.1. Introduction
  • 7.2. Desktop
  • 7.3. Mobile Phones & Tablets

8. Stroke Post Processing Software Market, by Modality

  • 8.1. Introduction
  • 8.2. CT Scan
  • 8.3. MRI

9. Stroke Post Processing Software Market, by End-use

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Specialty Centers

10. Americas Stroke Post Processing Software Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Stroke Post Processing Software Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Stroke Post Processing Software Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arterys Inc.
  • 2. Brainomix Limited
  • 3. Cercare Medical A/S
  • 4. Circle Cardiovascular Imaging Inc.
  • 5. General Electric Company
  • 6. icometrix NV
  • 7. Imaging Biometrics, LLC
  • 8. Infervision Medical Technology Co., Ltd.
  • 9. iSchemaView, Inc.
  • 10. Olea Medical S.A.S.
  • 11. Viz.ai, Inc.
  • 12. Vizient, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦